A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Blood glucose is tightly regulated by the opposing actions of insulin (fed state) and glucagon (fasted state). Insulin promotes glucose uptake and storage; glucagon mobilizes glucose through glycogenolysis and gluconeogenesis. The pancreatic islets sense glucose directly, responding without hormonal intermediates. Dysregulation of this system causes diabetes with severe metabolic consequences.
From your study of pancreatic beta cell function, you know that beta cells act as glucose sensors — they take up glucose proportionally to blood concentration via GLUT2 transporters, metabolize it, and the resulting rise in ATP closes ATP-sensitive K⁺ channels, depolarizing the cell and triggering insulin exocytosis. This direct sensing mechanism means the pancreas does not need external instructions to respond to a meal; it reads blood glucose in real time.
Insulin and glucagon function as a push-pull pair, like two opposing arms on a metabolic seesaw. After a meal, blood glucose rises above the fasting level of roughly 70–100 mg/dL. Beta cells respond by secreting insulin, which acts on target tissues to clear glucose from the blood. In skeletal muscle and adipose tissue, insulin stimulates translocation of GLUT4 transporters to the cell surface, dramatically increasing glucose uptake. In the liver, insulin activates glycogen synthase (promoting glucose storage as glycogen) and glucokinase (trapping glucose inside hepatocytes by phosphorylating it), while simultaneously suppressing gluconeogenesis and glycogenolysis. The net effect is that glucose is swept out of the blood and packed away as glycogen and fat. Blood glucose returns to baseline within a few hours.
When blood glucose drops — between meals, during sleep, or during exercise — the alpha cells of the pancreatic islets take over. Falling glucose *reduces* insulin secretion (removing the storage signal) and *increases* glucagon secretion. Glucagon acts primarily on the liver, activating glycogen phosphorylase to break glycogen back into glucose (glycogenolysis) and stimulating gluconeogenesis — the synthesis of new glucose from lactate, amino acids, and glycerol. The liver then releases this glucose into the blood, maintaining the supply to glucose-dependent organs like the brain. Notice the elegance: insulin and glucagon do not just oppose each other — they are reciprocally regulated. Rising glucose simultaneously stimulates insulin and suppresses glucagon; falling glucose does the reverse. This reciprocal control creates a tighter regulatory loop than either hormone could achieve alone.
The consequences of dysregulation reveal why this system matters. In type 1 diabetes, autoimmune destruction of beta cells eliminates insulin production. Without insulin, tissues cannot take up glucose despite abundant supply, blood glucose soars, and the body shifts to fat metabolism, producing dangerous levels of ketone bodies (diabetic ketoacidosis). In type 2 diabetes, tissues become resistant to insulin's signal — GLUT4 translocation is impaired, the liver fails to suppress glucose output — and beta cells eventually cannot compensate by producing more insulin. In both cases, the finely tuned glucose thermostat breaks, illustrating that the insulin-glucagon axis is not merely regulatory — it is essential for survival.